Sandoz Sitagliptin 50 mg (Sitagliptin (Sitagliptin Phosphate Monohydrate) TABLET) 50 MG

Sandoz Sitagliptin 50 mg tablets are a pharmaceutical product used to manage blood sugar levels. This oral medication is designed to support glucose control in adults with type 2 diabetes.

Strength

50 MG

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sitagliptin is commonly used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It works by increasing the levels of incretin hormones, which help the pancreas release insulin. This medication is often prescribed for individuals who require additional support in managing their blood sugar levels.

Side Effects

Sitagliptin may cause common side effects such as headache, upper respiratory infection, and nausea. Some users might experience mild gastrointestinal discomfort or dizziness. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Sitagliptin should be handled with care, especially by individuals with a history of kidney problems or pancreatitis. It is essential to follow the prescribed dosage and administration guidelines. Always store the medication in a cool, dry place away from direct sunlight and out of reach of children.

Avoid Interactions

Sitagliptin may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be moderated while using this medication.

Frequently Asked Questions

Sitagliptin is used to improve glycemic control in adults with type 2 diabetes, often in combination with diet and exercise.

Sitagliptin is typically taken orally, with or without food, as directed by a healthcare provider.

Common side effects may include headache, upper respiratory infection, nausea, and mild gastrointestinal discomfort.

Sitagliptin may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Sitagliptin should be used with caution in individuals with a history of kidney problems or pancreatitis, and it is essential to follow medical advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.